Maria Consuelo Alonso Cañizal

Maria Consuelo Alonso Cañizal

Auto-generated profile, based on publicly available information

Maria Consuelo Alonso Cañizal

Institute of Pharmacology and Toxicology, University of Würzburg, Versbacher Str. 9, 97078, Würzburg, Germany

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2017 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
LALuca Agnetta
Luca Agnetta
MKMichael Kauk
Michael Kauk
MCMaria Consuelo Alonso Canizal
Maria Consuelo Alonso Canizal
RMRegina Messerer
Regina Messerer
UHUlrike Holzgrabe
Ulrike Holzgrabe
MDMichael Decker
Michael Decker

21 January 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
PKPawel Kozielewicz
Pawel Kozielewicz
ATAinoleena Turku
Ainoleena Turku
CBCarl-Fredrik Bowin
Carl-Fredrik Bowin
JPJulian Petersen
Julian Petersen
JVJana Valnohova
Jana Valnohova
GSGunnar Schulte
Gunnar Schulte
WNT-Frizzled (FZD) signaling plays a critical role in embryonic development, stem cell regulation and tissue homeostasis. FZDs are linked to severe human pathology and are seen as a promising target for therapy. Despite intense efforts, no small molecule drugs with distinct efficacy have emerged. Here, we identify the Smoothened agonist SAG1.3 as a partial agonist of FZD6with limited subtype selectivity. Employing extensive in silico analysis, resonance energy transfer- and luciferase-based assays we describe the mode of action of SAG1.3. We define the ability of SAG1.3 to bind to FZD6and to induce conformational changes in the receptor, recruitment and activation of G proteins and dynamics in FZD–Dishevelled interaction. Our results provide the proof-of-principle that FZDs are targetable by small molecules acting on their seven transmembrane spanning core. Thus, we provide a starting point for a structure-guided and mechanism-based drug discovery process to exploit the potential of FZDs as therapeutic targets.

4 December 2018 in Science Signaling
Verified
Journal Article
Closed access
PDF file
SWShane C. Wright
Shane C. Wright
MCMaria Consuelo Alonso Cañizal
Maria Consuelo Alonso Cañizal
TBTobias Benkel
Tobias Benkel
KSKatharina Simon
Katharina Simon
CGChristian Le Gouill
Christian Le Gouill
CHCarsten Hoffmann
Carsten Hoffmann
Ligand binding induces conformational changes in FZD 5 , activation of heterotrimeric G proteins, and G q -dependent signaling.

18 April 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
JHJakub Harnoš
Jakub Harnoš
MCMaria Consuelo Alonso Cañizal
Maria Consuelo Alonso Cañizal
MJMiroslav Jurásek
Miroslav Jurásek
JKJitender Kumar
Jitender Kumar
CHCornelia Holler
Cornelia Holler
Vítězslav BryjaVítězslav Bryja
Vítězslav Bryja
Dishevelled (DVL) is the key component of the Wnt signaling pathway. Currently, DVL conformational dynamics under native conditions is unknown. To overcome this limitation, we develop the Fluorescein Arsenical Hairpin Binder- (FlAsH-) based FRET in vivo approach to study DVL conformation in living cells. Using this single-cell FRET approach, we demonstrate that (i) Wnt ligands induce open DVL conformation, (ii) DVL variants that are predominantly open, show more even subcellular localization and more efficient membrane recruitment by Frizzled (FZD) and (iii) Casein kinase 1 ɛ (CK1ɛ) has a key regulatory function in DVL conformational dynamics. In silico modeling and in vitro biophysical methods explain how CK1ɛ-specific phosphorylation events control DVL conformations via modulation of the PDZ domain and its interaction with DVL C-terminus. In summary, our study describes an experimental tool for DVL conformational sampling in living cells and elucidates the essential regulatory role of CK1ɛ in DVL conformational dynamics.

6 February 2017 in ACS Chemical Biology
Verified
Journal Article
Closed access
RMRegina Messerer
Regina Messerer
MKMichael Kauk
Michael Kauk
DVDaniela Volpato
Daniela Volpato
MCMaria Consuelo Alonso Canizal
Maria Consuelo Alonso Canizal
JKJessika Klöckner
Jessika Klöckner
UHUlrike Holzgrabe
Ulrike Holzgrabe

16 January 2014 in Autoimmune Diseases
Verified
Journal Article
Open access
PDF file
APAlejandro Caro Pérez
Alejandro Caro Pérez
SKSarita Kumble
Sarita Kumble
KKKrishnanand D. Kumble
Krishnanand D. Kumble
MCM. Consuelo Alonso Cañizal
M. Consuelo Alonso Cañizal
LJLuis M. Jiménez Jiménez
Luis M. Jiménez Jiménez
PPPilar Durán Parejo
Pilar Durán Parejo
The performance of immunoassays for the detection of autoantibodies is of critical importance in the diagnosis and assessment of patients with autoimmune connective tissue diseases (ACTD). Our objective was to compare the features of two multiplexed assays—INNO-LIA ANA and Gennova-PictArray ENA ELISA—for measurement of multiple autoantibodies and their utility as a clinical tool in ACTD diagnosis. The antigens included SS-A/Ro (60 and 52), SSB/La, Sm, Sm/RNP, CENP-B, Jo-1, and Scl-70. Stored sera from 85 ACTD patients and 80 controls consisting of patients with vasculitis, rheumatoid arthritis and infectious diseases, as well as healthy subjects were analyzed jointly with clinical and laboratory data. Agreement between the two methods varied between 58 and 99% (Cohen’s kappa: 0.21–0.71) mostly for SSA and SSB. The frequency of specific autoantibodies measured using the two methods was more variable for SSA, SSB, and RNP/Sm. There were a higher number of ambiguous results when using INNO-LIA. The optimized cut-off values of the Gennova-PictArray resulted in over 99% specificities in samples obtained from the control group. Sensitivity patterns were more accurate in Gennova-PictArray than in INNO-LIA, as suggested in previously reported studies. A third method could be applied to determine which of the two methods is more accurate.